231 related articles for article (PubMed ID: 7636268)
1. Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis.
Reiter Y; Ciobotariu A; Jones J; Morgan BP; Fishelson Z
J Immunol; 1995 Aug; 155(4):2203-10. PubMed ID: 7636268
[TBL] [Abstract][Full Text] [Related]
2. Sublytic complement attack protects tumor cells from lytic doses of antibody and complement.
Reiter Y; Ciobotariu A; Fishelson Z
Eur J Immunol; 1992 May; 22(5):1207-13. PubMed ID: 1577063
[TBL] [Abstract][Full Text] [Related]
3. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
[TBL] [Abstract][Full Text] [Related]
4. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
Jiang S; Persechini PM; Perussia B; Young JD
J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
[TBL] [Abstract][Full Text] [Related]
5. Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin.
Müller C; Tschopp J
J Immunol; 1994 Sep; 153(6):2470-8. PubMed ID: 7521362
[TBL] [Abstract][Full Text] [Related]
6. Perforin enhances the granulysin-induced lysis of Listeria innocua in human dendritic cells.
Walch M; Latinovic-Golic S; Velic A; Sundstrom H; Dumrese C; Wagner CA; Groscurth P; Ziegler U
BMC Immunol; 2007 Aug; 8():14. PubMed ID: 17705829
[TBL] [Abstract][Full Text] [Related]
7. Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis.
Pilzer D; Fishelson Z
Int Immunol; 2005 Sep; 17(9):1239-48. PubMed ID: 16091382
[TBL] [Abstract][Full Text] [Related]
8. Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+.
Carney DF; Hammer CH; Shin ML
J Immunol; 1986 Jul; 137(1):263-70. PubMed ID: 3711667
[TBL] [Abstract][Full Text] [Related]
9. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
Tschopp J; Masson D; Stanley KK
Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
[TBL] [Abstract][Full Text] [Related]
10. Expression and characterization of functionally active recombinant perforin produced in insect cells.
Liu CC; Persechini PM; Young JD
J Immunol; 1996 May; 156(9):3292-300. PubMed ID: 8617952
[TBL] [Abstract][Full Text] [Related]
11. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells.
Kilgore KS; Flory CM; Miller BF; Evans VM; Warren JS
Am J Pathol; 1996 Sep; 149(3):953-61. PubMed ID: 8780399
[TBL] [Abstract][Full Text] [Related]
12. Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process.
Kim SH; Carney DF; Hammer CH; Shin ML
J Immunol; 1987 Mar; 138(5):1530-6. PubMed ID: 2433349
[TBL] [Abstract][Full Text] [Related]
13. Cell desensitization by sublytic C5b-9 complexes and calcium ionophores depends on activation of protein kinase C.
Kraus S; Fishelson Z
Eur J Immunol; 2000 May; 30(5):1272-80. PubMed ID: 10820372
[TBL] [Abstract][Full Text] [Related]
14. Changes in intracellular calcium concentration and pH of target cells during the cytotoxic process: a quantitative study at the single cell level.
Radosević K; de Grooth BG; Greve J
Cytometry; 1995 Aug; 20(4):281-9. PubMed ID: 7587715
[TBL] [Abstract][Full Text] [Related]
15. Increased sensitivity of early apoptotic cells to complement-mediated lysis.
Attali G; Gancz D; Fishelson Z
Eur J Immunol; 2004 Nov; 34(11):3236-45. PubMed ID: 15368275
[TBL] [Abstract][Full Text] [Related]
16. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
17. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.
Miskovsky EP; Liu AY; Pavlat W; Viveen R; Stanhope PE; Finzi D; Fox WM; Hruban RH; Podack ER; Siliciano RF
J Immunol; 1994 Sep; 153(6):2787-99. PubMed ID: 7915742
[TBL] [Abstract][Full Text] [Related]
18. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
19. Arrest of the cell cycle reduces susceptibility of target cells to perforin-mediated lysis.
De Leon M; Jackson KM; Cavanaugh JR; Mbangkollo D; Verret CR
J Cell Biochem; 1998 Jun; 69(4):425-35. PubMed ID: 9620169
[TBL] [Abstract][Full Text] [Related]
20. Immunosensitization of resistant human tumor cells to cytotoxicity by tumor infiltrating lymphocytes.
Frost P; Caliliw R; Belldegrun A; Bonavida B
Int J Oncol; 2003 Feb; 22(2):431-7. PubMed ID: 12527945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
